HomeDisease EducationDMDDM1FSHDScientific MeetingsJournal ArticlesMedical Information RequestUpcoming EventsStay in Touch
Other Resources
Dyne Corporate WebsiteContinuing Medical Education

Welcome to Dyne Medical Central

At Dyne Therapeutics, we are focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. Dyne Medical Central is an educational hub designed to help healthcare professionals deepen their understanding of Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD).

Explore a variety of accessible, downloadable resources to expand your clinical knowledge!

The FORCE™ platform, zeleciment-basivarsen (z-basivarsen, formerly known as DYNE-101), zeleciment-rostudirsen (z-rostudirsen, formerly known as DYNE-251), DYNE-302, and DYNE-401 are investigational or otherwise in development and have not been approved as safe or effective by the US FDA, EMA or any other regulatory authority.

DISease education

Dive into educational resources on Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD).

Scientific meetings

Catch up on the latest scientific content from Dyne Therapeutics presented at national and international congresses.

Enter Here

journal articles

Access peer-reviewed journal articles sponsored by Dyne Therapeutics.

Enter Here

UPCOMING EVENTS

Stay in touch with Dyne Therapeutics at scientific congresses we will be attending

Enter Here

you are now leaving the
Dyne Medical Central website.

Dyne Therapeutics, Inc. supports accredited continuing education (CE) for healthcare professionals across therapeutic areas of interest. These CE activities are planned, developed and delivered by independent accredited providers in accordance with the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education, or the standards of other similar accrediting organizations. Dyne Therapeutics, Inc. does not exercise control over, or provide guidance to, any accredited provider. Dyne Therapeutics, Inc. is sharing CE information on this page as a service to the medical community and with permission from the accredited providers. The information on this page is intended to provide self-service to educational topics of interest, and most activities are free to the learner (some may require a nominal registration fee per the accredited provider’s requirements).

continue

Contact our Medical Information Team

Do you have a question about a Dyne Therapeutics investigational therapy?

Get in touch with our Medical Information team now.

Thank you for your submission,
a member of the team will be in touch in due course.

you are now leaving the Dyne Medical Central website.

continue

FOR healthcare professionals ONLY

The information provided on this website is for educational purposes only and should not be considered medical advice or professional services.

enter
The FORCE™ platform, zeleciment-basivarsen (z-basivarsen, formerly known as DYNE-101), zeleciment-rostudirsen (z-rostudirsen, formerly known as DYNE-251), DYNE-302, and DYNE-401 are investigational or otherwise in development and have not been approved as safe or effective by the US FDA, EMA or any other regulatory authority.

©2025 Dyne Therapeutics, Inc. All rights reserved MED-00911. Date of preparation: October 2025.

Are you a US healthcare professional?

No, I am not a US healthcare professional.

Yes, I am a US healthcare professional.

The FORCE™ platform, zeleciment-basivarsen (z-basivarsen, formerly known as DYNE-101), zeleciment-rostudirsen (z-rostudirsen, formerly known as DYNE-251), DYNE-302, and DYNE-401 are investigational or otherwise in development and have not been approved as safe or effective by the US FDA, EMA or any other regulatory authority.

©2025 Dyne Therapeutics, Inc. All rights reserved MED-00911. Date of preparation: October 2025.